Music therapy tested for rare muscle disease in kids
NCT ID NCT06809049
First seen Jun 27, 2026 · Last updated Jul 29, 2026 · Updated 2 times
Summary
This study explores whether weekly music and movement sessions are practical and enjoyable for children aged 6 to 18 with myotonic dystrophy type 1 (DM1). Over 10 weeks, participants attend 45-minute music classes, undergo physical and cognitive tests, and provide biological samples. The goal is to see if this approach can ease brain and heart symptoms and identify useful measures for future research.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOTONIC DYSTROPHY TYPE 1 (DM1) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Children's Hospital of Eastern Ontario
Ottawa, Ontario, K1H 8L1, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Scientists hunt for biomarkers to unlock DM1 treatments
- Could virtual reality help kids with a rare muscle disease read emotions better?
- Personalized exercise program aims to boost mobility in rare muscle diseases
- No travel needed: new study uses video calls to uncover genetic secrets of childhood muscle disease
- Brain scans reveal diabetes link to cognitive decline in rare disease
- New study aims to uncover why people with muscle disease fall